{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:40:44Z","timestamp":1785897644637,"version":"3.56.0"},"reference-count":30,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/100009931","name":"Michigan Department of Health and Human Services","doi-asserted-by":"publisher","award":["E20242492-002"],"award-info":[{"award-number":["E20242492-002"]}],"id":[{"id":"10.13039\/100009931","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA042859"],"award-info":[{"award-number":["R01DA042859"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2025,3,4]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the correlation of patient-reported opioid use as compared to fills verified in a prescription drug monitoring program (PDMP) before and after surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Correctly determining prescription opioid use before and after surgery is critical to develop effective policies and care pathways for opioid stewardship perioperatively. While many surgical teams, health systems, and patient registries rely on patients to report their use of prescription opioids, the accuracy of this reporting is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patient-reported data on opioid use from 12 225 adult patients who underwent surgical procedures between 1 January 2018 and 31 October 2019 across 70 participating hospitals in Michigan Surgical Quality Collaborative were compared to the reference standard of the state PDMP. The primary outcome was patient-reported opioid fill in the 30 days after surgery compared to PDMP-verified prescription fill, and the secondary outcomes were patient-reported use in the 30-day and 1-year period prior to surgery compared to PDMP data. Accuracy, sensitivity, specificity, and other predictive values were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 12 225 patients (58% women, 19.2% non-white, mean (SD) age 15.6 (16.3)), the patient report had acceptable accuracy (83.2%, 95% CI 82.5% to 83.9%) and sensitivity (91.2%, 95% CI 90.6% to 91.8%) compared to 30-day postoperative opioid fills in the PDMP, while less than half of patients without PDMP-verified fills accurately reported not filling an opioid prescription (specificity 43.1%, 95% CI 40.9% to 45.3%). For 30-day and 1-year periods before surgery, patient-reported opioid use had acceptable accuracy (86.8% (95% CI 86.1% to 87.4%) and 77.9% (95% CI 77.2% to 78.7%), respectively) and specificity (90.0% (95% CI 89.4% to 90.5%) and 90.8% (95% CI 90.2% to 91.4%), respectively), while only slightly above half of patients with PDMP-verified opioid fills reported opioid use before surgery (sensitivity 58.9% (95% CI 56.2% to 61.7%) and 47.3% (95% CI 45.7% to 49.0%), respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For perioperative opioid fills and use, the patient report appears to align with PDMP data. The patient report may also complement PDMP data by identifying persons who may report opioid prescription fills or use without corresponding data in the PDMP, especially in the postoperative period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rapm-2024-106090","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:52:08Z","timestamp":1742392328000},"page":"781-788","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Accuracy of patient-reported opioid use to verified prescription fills before and after surgery"],"prefix":"10.1136","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9011-3479","authenticated-orcid":false,"given":"Siddartha","family":"Simha","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Lamonge","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F","family":"Waljee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Michigan Medicine, Ann Arbor, Michigan, USA"},{"name":"Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ling","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Michigan Medicine, Ann Arbor, Michigan, USA"},{"name":"Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhya","family":"Gunaseelan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan, USA"},{"name":"Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Englesbe","sequence":"additional","affiliation":[{"name":"Department of Surgery, Michigan Medicine, Ann Arbor, Michigan, USA"},{"name":"Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad M","family":"Brummett","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan, USA"},{"name":"Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9406-5953","authenticated-orcid":false,"given":"Mark C","family":"Bicket","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan, USA"},{"name":"Overdose Prevention Engagement Network, Institute for Healthcare Policy and Innovation, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"2026071002301578000_51.7.781.1","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2021-103388"},{"key":"2026071002301578000_51.7.781.2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.1827"},{"key":"2026071002301578000_51.7.781.3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamasurg.2018.2102","article-title":"Prevalence of Preoperative Opioid Use and Characteristics Associated With Opioid Use Among Patients Presenting for Surgery","volume":"153","author":"Hilliard","year":"2018","journal-title":"JAMA Surg"},{"key":"2026071002301578000_51.7.781.4","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.2924","article-title":"Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program","volume":"2","author":"Shenoy","year":"2021","journal-title":"JAMA Health Forum"},{"key":"2026071002301578000_51.7.781.5","unstructured":"D\u2019Souza RS , Lang M , Eldridge JS . Prescription Drug Monitoring Program. StatPearls,"},{"key":"2026071002301578000_51.7.781.6","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxaa002"},{"key":"2026071002301578000_51.7.781.7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamasurg.2018.2666","article-title":"Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery","volume":"153","author":"Stucke","year":"2018","journal-title":"JAMA Surg"},{"key":"2026071002301578000_51.7.781.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109090"},{"key":"2026071002301578000_51.7.781.9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PHH.0000000000001210","article-title":"Prescription History Before Opioid Overdose Death: PDMP Data and Responsible Prescribing","volume":"27","author":"Shreffler","year":"2021","journal-title":"J Public Health Manag Pract"},{"key":"2026071002301578000_51.7.781.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.010"},{"key":"2026071002301578000_51.7.781.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2009.08.002"},{"key":"2026071002301578000_51.7.781.12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/SLA.0000000000003434","article-title":"A Pathway for Developing Postoperative Opioid Prescribing Best Practices","volume":"271","author":"Howard","year":"2020","journal-title":"Ann Surg"},{"key":"2026071002301578000_51.7.781.13","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.4234","article-title":"Association of Opioid Prescribing With Opioid Consumption After Surgery in Michigan","volume":"154","author":"Howard","year":"2019","journal-title":"JAMA Surg"},{"key":"2026071002301578000_51.7.781.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1905045"},{"key":"2026071002301578000_51.7.781.15","unstructured":"Michigan OPEN . Prescribing recommendations. n.d. Available: https:\/\/michigan-open.org\/prescribing-recommendations\/"},{"key":"2026071002301578000_51.7.781.16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamasurg.2017.1527","article-title":"Surgeon Variation in Complications With Minimally Invasive and Open Colectomy","volume":"152","author":"Healy","year":"2017","journal-title":"JAMA Surg"},{"key":"2026071002301578000_51.7.781.17","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2010.0526"},{"key":"2026071002301578000_51.7.781.18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/pme.12469","article-title":"How clinicians use prescription drug monitoring programs: a qualitative inquiry","volume":"15","author":"Hildebran","year":"2014","journal-title":"Pain Med"},{"key":"2026071002301578000_51.7.781.19","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"key":"2026071002301578000_51.7.781.20","doi-asserted-by":"crossref","first-page":"e1185","DOI":"10.1097\/SLA.0000000000005937","article-title":"Association Between Payer Type and Risk of Persistent Opioid Use After Surgery","volume":"278","author":"Srinivasan","year":"2023","journal-title":"Ann Surg"},{"key":"2026071002301578000_51.7.781.21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5055\/jom.2019.0540","article-title":"Validation of the prescription drug monitoring program Web site","volume":"15","author":"Hozack","year":"2019","journal-title":"J Opioid Manag"},{"key":"2026071002301578000_51.7.781.22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/acem.13352","article-title":"Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder","volume":"25","author":"Hawk","year":"2018","journal-title":"Acad Emerg Med"},{"key":"2026071002301578000_51.7.781.23","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.1852","article-title":"Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians: A Cluster Randomized Clinical Trial","volume":"3","author":"Neprash","year":"2022","journal-title":"JAMA Health Forum"},{"key":"2026071002301578000_51.7.781.24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.18094","article-title":"Analysis of Access to Prescription Data Management Programs Data for Research","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026071002301578000_51.7.781.25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMp1904714","article-title":"Prescription Drug Monitoring Programs - Friend or Folly in Addressing the Opioid-Overdose Crisis?","volume":"381","author":"Haffajee","year":"2019","journal-title":"N Engl J Med"},{"key":"2026071002301578000_51.7.781.26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jiph.2020.06.035","article-title":"Prescription drug monitoring programs in the US: A systematic literature review on its strength and weakness","volume":"13","author":"Alogaili","year":"2020","journal-title":"J Infect Public Health"},{"key":"2026071002301578000_51.7.781.27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.drugalcdep.2017.08.040","article-title":"Prescription drug monitoring program design and function: A qualitative analysis","volume":"180","author":"Rutkow","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"2026071002301578000_51.7.781.28","doi-asserted-by":"publisher","DOI":"10.1257\/pol.20160094"},{"key":"2026071002301578000_51.7.781.29","first-page":"SP541","article-title":"Adoption of electronic prescribing for controlled substances among providers and pharmacies","volume":"20","author":"Hufstader Gabriel","year":"2014","journal-title":"Am J Manag Care"},{"key":"2026071002301578000_51.7.781.30","doi-asserted-by":"crossref","first-page":"106861","DOI":"10.1016\/j.ypmed.2021.106861","article-title":"Impacts of prescription drug monitoring program policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California, 2015\u20132018","volume":"153","author":"Henry","year":"2021","journal-title":"Prev Med"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2024-106090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:30:43Z","timestamp":1783675843000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2024-106090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,6]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/rapm-2024-106090"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2024-106090","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]}}}